18 results
prevention treatment mycobacterium aviumcomplex bacterial bartonella bartonellosis candida candidiasis capsulatum chagas cmv coccidiodomycosis cryptococcosis cryptococcus cytomegalovirus diabetic disease encephalitis enteric
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS Preventing Bacterial Enteric Illness: • Antimicrobial
IDSA Recommendations ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS Treating Visceral Leishmaniasis - Preferred Therapy: •
IDSA Recommendations ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS Indications for Initiating Primary Prophylaxis: •
IDSA Recommendations ... Prevention #Treatment #opportunistic ... #infections #HIVAIDS ... #management #pharmacology ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
IDSA Recommendations ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS Preventing Clinical Disease Indication: Individuals
IDSA Recommendations ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS Treating Orolabial Lesions (Duration: 5–10 days)
acyclovir 5 mg/kg ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS Preventing CMV Disease: • CMV end-organ disease is best
., concomitant medications ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS Indications for Initiating Primary Prophylaxis: •
with ARV (see Table ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
No results found for "HOCM ekg causes management syndrome classification pharmacology medications table idsa hivaids opportunistic infections"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #HOCM #ekg #causes #management #syndrome #classification #pharmacology #medications #table #idsa #hivaids #opportunistic #infections